| 1 |
Hutton D, Mustafa A, Patil S, Rathod S, Shrikhande G, Advincula A, Drummond J, Gregersen P, Hall J, Metz C, Milspaw A, Orbuch IK, Stahl P, Stein A, Shrikhande A. The burden of Chronic Pelvic Pain (CPP): Costs and quality of life of women and men with CPP treated in outpatient referral centers. PLoS One 2023;18:e0269828. [PMID: 36757947 DOI: 10.1371/journal.pone.0269828] [Reference Citation Analysis]
|
| 2 |
Deutsch L, Cloutier A, Leahy G, Teubner A, Abraham A, Taylor M, Paine P, Lal S. Factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure. Nutr Clin Pract 2023;38:129-37. [PMID: 36184884 DOI: 10.1002/ncp.10916] [Reference Citation Analysis]
|
| 3 |
Patel D, Khodadadi A, Jadcherla A, Rengarajan A, Rogers BD, Gyawali CP. Chronic opioid users with dysphagia are indistinguishable from symptomatic nonusers on functional lumen imaging probe evaluation. Neurogastroenterol Motil 2022;:e14519. [PMID: 36578248 DOI: 10.1111/nmo.14519] [Reference Citation Analysis]
|
| 4 |
LeBrett WG, Iyengar PS, Lee AH, Chen FW, Chang L. High Opioid Prescribing Profiles Among Gastroenterologists: A Nationwide Analysis. Clin Gastroenterol Hepatol 2022;20:2918-2920.e1. [PMID: 34666155 DOI: 10.1016/j.cgh.2021.10.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Wilson RD. Cesarean delivery using an ERAS-CD process for nonopioid anesthesia and analgesia drug/medication management. Best Pract Res Clin Obstet Gynaecol 2022;85:35-52. [PMID: 35995654 DOI: 10.1016/j.bpobgyn.2022.07.004] [Reference Citation Analysis]
|
| 6 |
Muhlenbrock CV, Nuñez P, Quera R, Madrid AM. Narcotic Bowel Syndrome, an Under-recognized Cause of Chronic Abdominal Pain in Adults. J Neurogastroenterol Motil 2022;28:706-8. [PMID: 36250376 DOI: 10.5056/jnm22114] [Reference Citation Analysis]
|
| 7 |
Balbale SN, Iroz CB, Schäfer WLA, Johnson JK, Stulberg JJ. A Missing Piece of the Puzzle: Patient and Provider Perspectives on Pain Management Needs and Opioid Prescribing in Inflammatory Bowel Disease Care. Crohns Colitis 360 2022;4:otac033. [PMID: 36777413 DOI: 10.1093/crocol/otac033] [Reference Citation Analysis]
|
| 8 |
Törnblom H. Editorial: rectal hyposensitivity in patients with hypermobile Ehlers-Danlos syndrome and constipation. Aliment Pharmacol Ther 2022;56:905-6. [PMID: 35934859 DOI: 10.1111/apt.17134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Rabinowitz LG, Zylberberg HM, Yang J, Gold SL, Chesner J, Ji J, Hu L, Dubinsky M. De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease. Dig Dis Sci 2022;67:4033-42. [PMID: 34613501 DOI: 10.1007/s10620-021-07257-y] [Reference Citation Analysis]
|
| 10 |
Kamperidis N, Nightingale J. Neurological disorders and small bowel dysmotility. Curr Opin Gastroenterol 2022;38:299-306. [PMID: 35645022 DOI: 10.1097/MOG.0000000000000836] [Reference Citation Analysis]
|
| 11 |
Keller J, Wedel T, Seidl H, Kreis ME, van der Voort I, Gebhard M, Langhorst J, Lynen Jansen P, Schwandner O, Storr M, van Leeuwen P, Andresen V, Preiß JC, Layer P, Allescher H, Andus T, Bischoff SC, Buderus S, Claßen M, Ehlert U, Elsenbruch S, Engel M, Enninger A, Fischbach W, Freitag M, Frieling T, Gillessen A, Goebel-Stengel M, Gschossmann J, Gundling F, Haag S, Häuser W, Helwig U, Hollerbach S, Holtmann G, Karaus M, Katschinski M, Krammer H, Kruis W, Kuhlbusch-Zicklam R, Lynen Jansen P, Madisch A, Matthes H, Miehlke S, Mönnikes H, Müller-Lissner S, Niesler B, Pehl C, Pohl D, Posovszky C, Raithel M, Röhrig-Herzog G, Schäfert R, Schemann M, Schmidt-Choudhury A, Schmiedel S, Schweinlin A, Schwille-Kiuntke J, Stengel A, Tesarz J, Voderholzer W, von Boyen G, von Schönfeld J; in Zusammenarbeit mit:., Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM)., Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)., Deutsche Gesellschaft für Ernährungsmedizin (DGEM)., Deutsche Gesellschaft für Geriatrie (DGG)., Deutsche Gesellschaft für Innere Medizin (DGIM)., Deutsche Gesellschaft für Naturheilkunde (DGNHK)., Deutsche Gesellschaft für Pathologie und Bundesverband deutscher Pathologen e. V. (DGP/BDP)., Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM)., Deutsche Gesellschaft für Verhaltensmedizin und Verhaltensmodifikation (DGVM)., Deutsche Schmerzgesellschaft e. V., Deutsches Kollegium für Psychosomatische Medizin (DKPM)., Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG)., Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE)., Deutsche Gesellschaft für Kinder- und Jugendmedizin (DGKJ)., Swiss Society of Neurogastroenterology and Motility (SwissNGM)., Informationsforum für Patient:innen mit Magen-Darm-Erkrankungen (MAGDA). Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). Z Gastroenterol 2022;60:192-218. [PMID: 35148561 DOI: 10.1055/a-1646-1279] [Reference Citation Analysis]
|
| 12 |
Tran JP, Horine SV. Title: Novel Analgesic Potential of ß2-Agonists for Neuropathic Pain via ß2-Agonist Action. Curr Pain Headache Rep 2022. [PMID: 35129823 DOI: 10.1007/s11916-022-01006-0] [Reference Citation Analysis]
|
| 13 |
Wynne J, Kozuch P. Medical marijuana for inflammatory bowel disease: the highs and lows. Scand J Gastroenterol 2022;57:197-205. [PMID: 34919496 DOI: 10.1080/00365521.2021.1998604] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Gottesman-katz L, Borlack R, Khlevner J. Drugs Acting on the Brain. Pediatric Neurogastroenterology 2022. [DOI: 10.1007/978-3-031-15229-0_44] [Reference Citation Analysis]
|
| 15 |
Bousvaros A. Management of Pediatric Patients Hospitalized with Ulcerative. Management of Inpatient Inflammatory Bowel Disease 2022. [DOI: 10.1007/978-1-0716-1987-2_11] [Reference Citation Analysis]
|
| 16 |
Cruz-Lebrón A, Johnson R, Mazahery C, Troyer Z, Joussef-Piña S, Quiñones-Mateu ME, Strauch CM, Hazen SL, Levine AD. Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity. Gut Microbes 2021;13:1946368. [PMID: 34313547 DOI: 10.1080/19490976.2021.1946368] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 17 |
Chakraborty S, Uprety R, Slocum ST, Irie T, Le Rouzic V, Li X, Wilson LL, Scouller B, Alder AF, Kruegel AC, Ansonoff M, Varadi A, Eans SO, Hunkele A, Allaoa A, Kalra S, Xu J, Pan YX, Pintar J, Kivell BM, Pasternak GW, Cameron MD, McLaughlin JP, Sames D, Majumdar S. Oxidative Metabolism as a Modulator of Kratom's Biological Actions. J Med Chem 2021;64:16553-72. [PMID: 34783240 DOI: 10.1021/acs.jmedchem.1c01111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Lambert BL, Jordan N, Keefer LA. High-Dose Opioid Use Among Veterans with Unexplained Gastrointestinal Symptoms Versus Structural Gastrointestinal Diagnoses. Dig Dis Sci 2021;66:3938-50. [PMID: 33385263 DOI: 10.1007/s10620-020-06742-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 19 |
Drewes AM, van Veldhuisen CL, Bellin MD, Besselink MG, Bouwense SA, Olesen SS, van Santvoort H, Vase L, Windsor JA. Assessment of pain associated with chronic pancreatitis: An international consensus guideline. Pancreatology 2021;21:1256-84. [PMID: 34391675 DOI: 10.1016/j.pan.2021.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 20 |
Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Jordan N, Keefer LA, Lambert BL. Opioid-related emergency department visits and hospitalizations among patients with chronic gastrointestinal symptoms and disorders dually enrolled in the Department of Veterans Affairs and Medicare Part D. Am J Health Syst Pharm 2021:zxab363. [PMID: 34491281 DOI: 10.1093/ajhp/zxab363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 21 |
Gadais C, Piekielna-Ciesielska J, De Neve J, Martin C, Janecka A, Ballet S. Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist-Neurokinin Antagonist Peptidomimetics. Molecules 2021;26:5406. [PMID: 34500841 DOI: 10.3390/molecules26175406] [Reference Citation Analysis]
|
| 22 |
Wise JL, Vazquez-Roque MI, McKinney CJ, Zickella MA, Crowell MD, Lacy BE. Gastric Emptying Scans: Poor Adherence to National Guidelines. Dig Dis Sci 2021;66:2897-906. [PMID: 32418002 DOI: 10.1007/s10620-020-06314-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 23 |
Törnblom H, Drossman DA. Psychopharmacologic Therapies for Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:655-69. [PMID: 34304793 DOI: 10.1016/j.gtc.2021.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 24 |
Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Lambert BL, Keefer LA, Jordan N. Characteristics of Opioid Prescriptions to Veterans With Chronic Gastrointestinal Symptoms and Disorders Dually Enrolled in the Department of Veterans Affairs and Medicare Part D. Mil Med 2021;186:943-50. [PMID: 33693755 DOI: 10.1093/milmed/usab095] [Reference Citation Analysis]
|
| 25 |
De Giorgio R, Zucco FM, Chiarioni G, Mercadante S, Corazziari ES, Caraceni A, Odetti P, Giusti R, Marinangeli F, Pinto C. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel. Adv Ther 2021;38:3589-621. [PMID: 34086265 DOI: 10.1007/s12325-021-01766-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Shah I, Sheth SG, Kothari DJ. Pain management in chronic pancreatitis incorporating safe opioid practices: Challenge accepted. World J Gastroenterol 2021; 27(23): 3142-3147 [PMID: 34163102 DOI: 10.3748/wjg.v27.i23.3142] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 27 |
Shearin AE, Moufarrij NA. Twelve years of success in treating a patient with chronic visceral abdominal pain using paddle spinal cord stimulation. Interdisciplinary Neurosurgery 2021;24:101050. [DOI: 10.1016/j.inat.2020.101050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 28 |
Vasant DH, Lal S. Recent Advances in the Management of Severe Gastrointestinal Dysmotility. Clin Exp Gastroenterol 2021;14:163-72. [PMID: 34007199 DOI: 10.2147/CEG.S249877] [Reference Citation Analysis]
|
| 29 |
Mark EB, Frøkjær JB, Hansen TM, Nedergaard RB, Drewes AM. Although tapentadol and oxycodone both increase colonic volume, tapentadol treatment resulted in softer stools and less constipation: a mechanistic study in healthy volunteers. Scand J Pain 2021;21:406-14. [PMID: 33606931 DOI: 10.1515/sjpain-2020-0151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 30 |
Brenner DM, Argoff CE, Fox SM, Bochenek W, D'Astoli P, Blakesley RE, Reasner DS, O'Dea CR, Cash BD. Efficacy and safety of linaclotide for opioid-induced constipation in patients with chronic noncancer pain syndromes from a phase 2 randomized study. Pain 2020;161:1027-36. [PMID: 32310620 DOI: 10.1097/j.pain.0000000000001754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 31 |
Murphy LK, de la Vega R, Kohut SA, Kawamura JS, Levy RL, Palermo TM. Systematic Review: Psychosocial Correlates of Pain in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:697-710. [PMID: 32458966 DOI: 10.1093/ibd/izaa115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 32 |
Szigethy EM, Murphy SM, Ehrlich OG, Heller CA, Engel-Nitz NM, Meadows P, Allen JI. Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease. Crohns Colitis 360 2021;3:otab021. [PMID: 36778940 DOI: 10.1093/crocol/otab021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 33 |
LeBrett WG, Chen FW, Yang L, Chang L. Increasing Rates of Opioid Prescriptions for Gastrointestinal Diseases in the United States. Am J Gastroenterol 2021;116:796-807. [PMID: 33982950 DOI: 10.14309/ajg.0000000000001052] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 34 |
Southerland WA, Gillis J, Kuppalli S, Fonseca A, Mendelson A, Horine SV, Bansal N, Gulati A. Dual Enkephalinase Inhibitors and Their Role in Chronic Pain Management. Curr Pain Headache Rep 2021;25:29. [PMID: 33761014 DOI: 10.1007/s11916-021-00949-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Lam CY, Palsson OS, Whitehead WE, Sperber AD, Tornblom H, Simren M, Aziz I. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome. Clin Gastroenterol Hepatol 2021;19:277-287.e3. [PMID: 32109633 DOI: 10.1016/j.cgh.2020.02.034] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 36 |
Van Cleave JH, Booker SQ, Powell-Roach K, Liang E, Kawi J. A Scoping Review of Nursing's Contribution to the Management of Patients with Pain and Opioid Misuse. Pain Manag Nurs 2021;22:58-68. [PMID: 33414010 DOI: 10.1016/j.pmn.2020.11.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 37 |
Melchior C, Desprez C, Wuestenberghs F, Leroi AM, Lemaire A, Goucerol G. Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders. Front Pharmacol 2020;11:596467. [PMID: 33414719 DOI: 10.3389/fphar.2020.596467] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 38 |
Murphy LK, Suskind DL, Qu P, Zhou C, Gashi K, Kawamura JS, Palermo TM; ImproveCareNow Pediatric IBD Learning Health System, as stipulated by ICN. Abdominal Pain After Pediatric Inflammatory Bowel Disease Diagnosis: Results From the ImproveCareNow Network. J Pediatr Gastroenterol Nutr 2020;71:749-54. [PMID: 32910089 DOI: 10.1097/MPG.0000000000002933] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 39 |
Ahmed A, Yakah W, Freedman SD, Kothari DJ, Sheth SG. Evaluation of Opioid Use in Acute Pancreatitis in Absence of Chronic Pancreatitis: Absence of Opioid Dependence an Important Feature. Am J Med 2020;133:1209-18. [PMID: 32272099 DOI: 10.1016/j.amjmed.2020.03.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 40 |
Kitano M, Gress TM, Garg PK, Itoi T, Irisawa A, Isayama H, Kanno A, Takase K, Levy M, Yasuda I, Lévy P, Isaji S, Fernandez-Del Castillo C, Drewes AM, Sheel ARG, Neoptolemos JP, Shimosegawa T, Boermeester M, Wilcox CM, Whitcomb DC. International consensus guidelines on interventional endoscopy in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club. Pancreatology 2020;20:1045-55. [PMID: 32792253 DOI: 10.1016/j.pan.2020.05.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 41 |
Salwen-Deremer JK, Siegel CA, Smith MT. Cognitive Behavioral Therapy for Insomnia: A Promising Treatment for Insomnia, Pain, and Depression in Patients With IBD. Crohns Colitis 360 2020;2:otaa052. [PMID: 36776493 DOI: 10.1093/crocol/otaa052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Häuser W, Marschall U, Layer P, Grobe T. The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome. Dtsch Arztebl Int 2019;116:463-70. [PMID: 31431234 DOI: 10.3238/arztebl.2019.0463] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 43 |
Berry SK, Takakura W, Bresee C, Melmed GY. Pain in Inflammatory Bowel Disease Is Not Improved During Hospitalization: The Impact of Opioids on Pain and Healthcare Utilization. Dig Dis Sci 2020;65:1777-83. [PMID: 31654314 DOI: 10.1007/s10620-019-05906-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Stein C. Opioid analgesia: recent developments. Current Opinion in Supportive & Palliative Care 2020;14:112-7. [DOI: 10.1097/spc.0000000000000495] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 45 |
Habib AM, Nagi K, Thillaiappan NB, Sukumaran V, Akhtar S. Vitamin D and Its Potential Interplay With Pain Signaling Pathways. Front Immunol 2020;11:820. [PMID: 32547536 DOI: 10.3389/fimmu.2020.00820] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 46 |
Weaver E, Szigethy E. Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist. Curr Gastroenterol Rep 2020;22:20. [PMID: 32185521 DOI: 10.1007/s11894-020-0757-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 47 |
Mark EB, Klinge MW, Grønlund D, Poulsen JL, Schlageter V, Scott SM, Krogh K, Drewes AM. Ambulatory assessment of colonic motility using the electromagnetic capsule tracking system: Effect of opioids. Neurogastroenterol Motil 2020;32:e13753. [PMID: 31721398 DOI: 10.1111/nmo.13753] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 48 |
Sweeney L, Moss-Morris R, Czuber-Dochan W, Murrells T, Norton C. Developing a better biopsychosocial understanding of pain in inflammatory bowel disease: a cross-sectional study. Eur J Gastroenterol Hepatol 2020;32:335-44. [PMID: 31851083 DOI: 10.1097/MEG.0000000000001615] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 49 |
Chen FW, Lebrett WG, Yang L, Chang L. Opioid Prescription Patterns Among US Gastroenterologists From 2013 to 2017. Gastroenterology 2020;158:776-779.e2. [DOI: 10.1053/j.gastro.2019.10.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 50 |
Drewes AM, Olesen AE, Farmer AD, Szigethy E, Rebours V, Olesen SS. Gastrointestinal pain. Nat Rev Dis Primers 2020;6:1. [PMID: 31907359 DOI: 10.1038/s41572-019-0135-7] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 32.3] [Reference Citation Analysis]
|
| 51 |
Murphy LK, Rights JD, Ricciuto A, Church PC, Ahola Kohut S. Biopsychosocial Correlates of Presence and Intensity of Pain in Adolescents With Inflammatory Bowel Disease. Front Pediatr 2020;8:559. [PMID: 33014942 DOI: 10.3389/fped.2020.00559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 52 |
Simoni AH, Ladebo L, Christrup LL, Drewes AM, Johnsen SP, Olesen AE. Chronic abdominal pain and persistent opioid use after bariatric surgery. Scandinavian Journal of Pain 2020;20:239-51. [DOI: 10.1515/sjpain-2019-0092] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 53 |
Bharucha AE, Kudva YC, Prichard DO. Diabetic Gastroparesis. Endocr Rev 2019;40:1318-52. [PMID: 31081877 DOI: 10.1210/er.2018-00161] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 54 |
Wang Z, Xu B, Jiang C, Zhang T, Zhang M, Li N, Zhang Q, Xu K, Chen D, Xiao J, Fang Q. Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects. J Pain 2020;21:477-93. [PMID: 31521796 DOI: 10.1016/j.jpain.2019.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 55 |
Drewes AM, Kempeneers MA, Andersen DK, Arendt-Nielsen L, Besselink MG, Boermeester MA, Bouwense S, Bruno M, Freeman M, Gress TM, van Hooft JE, Morlion B, Olesen SS, van Santvoort H, Singh V, Windsor J. Controversies on the endoscopic and surgical management of pain in patients with chronic pancreatitis: pros and cons! Gut 2019;68:1343-51. [PMID: 31129569 DOI: 10.1136/gutjnl-2019-318742] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 56 |
Thapa N, Kappus M, Hurt R, Diamond S. Implications of the Opioid Epidemic for the Clinical Gastroenterology Practice. Curr Gastroenterol Rep 2019;21. [DOI: 10.1007/s11894-019-0712-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 57 |
Stein C, Kopf A. Pain therapy - Are there new options on the horizon? Best Pract Res Clin Rheumatol 2019;33:101420. [PMID: 31703793 DOI: 10.1016/j.berh.2019.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 58 |
Stein C. [Pain inhibition by opioids-new concepts]. Schmerz 2019;33:295-302. [PMID: 31222410 DOI: 10.1007/s00482-019-0386-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 59 |
Kilgallon E, Vasant DH, Green D, Shields PL, Hamdy S, Lal S, Paine P. Chronic continuous abdominal pain: evaluation of diagnostic features, iatrogenesis and drug treatments in a cohort of 103 patients. Aliment Pharmacol Ther 2019;49:1282-92. [PMID: 30950110 DOI: 10.1111/apt.15241] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 60 |
Stein C. [Pain inhibition by opioids-new concepts]. Anaesthesist 2019;68:97-103. [PMID: 30645691 DOI: 10.1007/s00101-018-0528-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 61 |
Kahrilas PJ, Bredenoord AJ, Carlson DA, Pandolfino JE. Advances in Management of Esophageal Motility Disorders. Clin Gastroenterol Hepatol 2018;16:1692-700. [PMID: 29702296 DOI: 10.1016/j.cgh.2018.04.026] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 62 |
Avalos DJ, Sarosiek I, Loganathan P, McCallum RW. Diabetic gastroparesis: current challenges and future prospects. Clin Exp Gastroenterol 2018;11:347-63. [PMID: 30310300 DOI: 10.2147/CEG.S131650] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 63 |
Stein C. New concepts in opioid analgesia. Expert Opin Investig Drugs 2018;27:765-75. [PMID: 30148648 DOI: 10.1080/13543784.2018.1516204] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 14.2] [Reference Citation Analysis]
|
| 64 |
Lattanzi R, Rief S, Schmidhammer H, Negri L, Spetea M. In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice. Front Pharmacol 2018;9:1002. [PMID: 30233377 DOI: 10.3389/fphar.2018.01002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 65 |
Glauser J, Money S. Medical Management of Pain in the Emergency Setting Without Narcotics: Current Status and Future Options. Curr Emerg Hosp Med Rep 2018;6:134-40. [DOI: 10.1007/s40138-018-0164-7] [Reference Citation Analysis]
|
| 66 |
Drossman DA, Tack J, Ford AC, Szigethy E, Törnblom H, Van Oudenhove L. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report. Gastroenterology 2018;154:1140-1171.e1. [PMID: 29274869 DOI: 10.1053/j.gastro.2017.11.279] [Cited by in Crossref: 195] [Cited by in F6Publishing: 193] [Article Influence: 39.0] [Reference Citation Analysis]
|
